Ali Farhoudian, Emran Razaghi, Zahra Hooshyari, Alireza Noroozi, Azam Pilevari, Azarakhsh Mokri, Mohammad Reza Mohammadi, Mohsen Malekinejad
{"title":"Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews.","authors":"Ali Farhoudian, Emran Razaghi, Zahra Hooshyari, Alireza Noroozi, Azam Pilevari, Azarakhsh Mokri, Mohammad Reza Mohammadi, Mohsen Malekinejad","doi":"10.1177/11782218221118462","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This investigation explored the barriers and facilitators to substance use disorder (SUD) treatment in the integrated paradigm.</p><p><strong>Methods: </strong>A search technique for barriers and facilitators of SUD treatment was applied to the PubMed and Web of Science databases to identify relevant systematic reviews. The eligibility criteria included systematic review (SR) or SR plus meta-analysis (MA) articles published before the end of 2021, human research, and the English language. Each of the 12 relevant review articles met the inclusion criteria. AMSTAR was utilised to evaluate the methodological quality of the systematic reviews.</p><p><strong>Results: </strong>Two authors analysed 12 SR/SR-MA articles to identify barriers or facilitators of SUD treatment. The cumulative summary results of these 12 evaluations revealed that barriers and facilitators may be classified into 3 levels: individual, social and structural. By analysing these review papers, 37 structural barriers, 21 individual barriers and 19 social barriers were uncovered, along with 15 structural facilitators, 9 social facilitators and 3 individual facilitators.</p><p><strong>Conclusions: </strong>The majority of barriers indicated in the review articles included in this analysis are structural, as are the majority of facilitators. Consequently, the design of macro models for the treatment of substance use disorders may yield various outcomes and potentially affect society and individual levels.</p>","PeriodicalId":22185,"journal":{"name":"Substance Abuse: Research and Treatment","volume":" ","pages":"11782218221118462"},"PeriodicalIF":2.4000,"publicationDate":"2022-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/b3/10.1177_11782218221118462.PMC9434658.pdf","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Abuse: Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11782218221118462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 9
Abstract
Objective: This investigation explored the barriers and facilitators to substance use disorder (SUD) treatment in the integrated paradigm.
Methods: A search technique for barriers and facilitators of SUD treatment was applied to the PubMed and Web of Science databases to identify relevant systematic reviews. The eligibility criteria included systematic review (SR) or SR plus meta-analysis (MA) articles published before the end of 2021, human research, and the English language. Each of the 12 relevant review articles met the inclusion criteria. AMSTAR was utilised to evaluate the methodological quality of the systematic reviews.
Results: Two authors analysed 12 SR/SR-MA articles to identify barriers or facilitators of SUD treatment. The cumulative summary results of these 12 evaluations revealed that barriers and facilitators may be classified into 3 levels: individual, social and structural. By analysing these review papers, 37 structural barriers, 21 individual barriers and 19 social barriers were uncovered, along with 15 structural facilitators, 9 social facilitators and 3 individual facilitators.
Conclusions: The majority of barriers indicated in the review articles included in this analysis are structural, as are the majority of facilitators. Consequently, the design of macro models for the treatment of substance use disorders may yield various outcomes and potentially affect society and individual levels.
目的:探讨综合范式下物质使用障碍(SUD)治疗的障碍和促进因素。方法:在PubMed和Web of Science数据库中应用障碍和促进因素搜索技术,识别相关的系统评价。入选标准包括2021年底前发表的系统评价(SR)或SR加meta分析(MA)文章、人类研究和英语。12篇相关综述文章均符合纳入标准。AMSTAR用于评价系统评价的方法学质量。结果:两位作者分析了12篇SR/SR- ma文章,以确定SUD治疗的障碍或促进因素。这12项评估的累积总结结果表明,障碍和促进因素可分为3个层面:个人、社会和结构。通过分析这些综述论文,发现了37个结构性障碍、21个个体障碍和19个社会障碍,以及15个结构性促进因素、9个社会促进因素和3个个体促进因素。结论:本分析中纳入的综述文章中指出的大多数障碍是结构性的,大多数促进因素也是如此。因此,物质使用障碍治疗的宏观模型设计可能产生各种结果,并可能影响社会和个人水平。